Systemic Hydrocortisone To Prevent Bronchopulmonary Dysplasia in preterm infants (the SToP-BPD study); a multicenter randomized placebo controlled trial

Wes Onland, Martin Offringa, Filip Cools, Anne P. De Jaegere, Karin Rademaker, Henry Blom, Eric Cavatorta, Anne Debeer, Peter H. Dijk, Arno F. van Heijst, Boris W. Kramer, Andre A. Kroon, Thilo Mohns, Henrica L M van Straaten, Arjan B. te Pas, Claire Theyskens, Mirjam M. van Weissenbruch, Anton H. van Kaam

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)102
JournalBmc Pediatrics
Volume11
Issue number1
DOIs
Publication statusPublished - 9 Nov 2011

Cite this

Onland, W., Offringa, M., Cools, F., De Jaegere, A. P., Rademaker, K., Blom, H., Cavatorta, E., Debeer, A., Dijk, P. H., van Heijst, A. F., Kramer, B. W., Kroon, A. A., Mohns, T., van Straaten, H. L. M., te Pas, A. B., Theyskens, C., van Weissenbruch, M. M., & van Kaam, A. H. (2011). Systemic Hydrocortisone To Prevent Bronchopulmonary Dysplasia in preterm infants (the SToP-BPD study); a multicenter randomized placebo controlled trial. Bmc Pediatrics, 11(1), 102. https://doi.org/10.1186/1471-2431-11-102